{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:01:47Z","timestamp":1790744507570,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1124\/mol.106.024653","type":"journal-article","created":{"date-parts":[[2006,8,16]],"date-time":"2006-08-16T02:48:57Z","timestamp":1155696537000},"page":"1585-1592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance"],"prefix":"10.1016","volume":"70","author":[{"given":"Charlotte A.","family":"Lanteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi L.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent P.","family":"Alibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Meshnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Tidwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.024653_REF1","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1021\/jm030604o","article-title":"O-Alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection","volume":"47","author":"Ansede","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/mol.106.024653_REF2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00001432-200012000-00012","article-title":"Problems for the chemotherapy of human African trypanosomiasis","volume":"13","author":"Barrett","year":"2000","journal-title":"Curr Opin Infect Dis"},{"key":"10.1124\/mol.106.024653_REF3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1124\/mol.106.024653_REF4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0169-4758(99)01414-3","article-title":"The biochemical basis of arsenical-diamidine cross-resistance in African trypanosomes","volume":"15","author":"Barrett","year":"1999","journal-title":"Parasitology Today"},{"key":"10.1124\/mol.106.024653_REF5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0166-6851(95)00120-P","article-title":"A diamidineresistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity","volume":"73","author":"Barrett","year":"1995","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.106.024653_REF6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the African trypanosome Trypanosoma brucei","volume":"309","author":"Berriman","year":"2005","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.024653_REF7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1046\/j.1365-3156.2001.00775.x","article-title":"The phenomenon of treatment failures in human African trypanosomiasis","volume":"6","author":"Brun","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1124\/mol.106.024653_REF8","series-title":"The Trypanosomiases","first-page":"403","article-title":"Current chemotherapy of human African trypanosomiasis","author":"Burri","year":"2004"},{"key":"10.1124\/mol.106.024653_REF9","doi-asserted-by":"crossref","first-page":"28153","DOI":"10.1074\/jbc.270.47.28153","article-title":"Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei","volume":"270","author":"Carter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.024653_REF10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/361173a0","article-title":"Arsenical-resistant trypanosomes lack an unusual adenosine transporter","volume":"361","author":"Carter","year":"1993","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.106.024653_REF11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0020-7519(01)00167-9","article-title":"Transporters in African trypanosomes: role in drug action and resistance","volume":"31","author":"de Koning","year":"2001","journal-title":"Int J Parasitol"},{"key":"10.1124\/mol.106.024653_REF12","first-page":"586","article-title":"Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals","volume":"59","author":"de Koning","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.024653_REF13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/AAC.48.5.1515-1519.2004","article-title":"The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in African trypanosomes","volume":"48","author":"de Koning","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.106.024653_REF14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-2952(00)00477-9","article-title":"Uptake and mode of action of drugs used against sleeping sickness","volume":"61","author":"Denise","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.106.024653_REF15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1124\/mol.106.024653_REF16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/mol.104.010298","article-title":"Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1\/P2 revisited","volume":"68","author":"Geiser","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.024653_REF17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum-protein without feeder cell-layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J Parasitol"},{"key":"10.1124\/mol.106.024653_REF18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001432-200412000-00009","article-title":"Treatment and control of human African trypanosomiasis","volume":"17","author":"Jannin","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1124\/mol.106.024653_REF19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/2181273a0","article-title":"Separation of trypanosomes from blood of infected rats and mice by anion-exchangers","volume":"218","author":"Lanham","year":"1968","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.106.024653_REF20","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/AAC.48.10.3968-3974.2004","article-title":"DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae","volume":"48","author":"Lanteri","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.106.024653_REF21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0035-9203(99)90151-7","article-title":"Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda","volume":"93","author":"Legros","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/mol.106.024653_REF22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.285.5425.242","article-title":"A nucleoside transporter from Trypanosoma brucei involved in drug resistance","volume":"285","author":"Maser","year":"1999","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.024653_REF23","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.00192-06","article-title":"Accumulation and intracellular distribution of anti-trypanosomal diamidine compounds DB75 and DB820 in African trypanosomes","volume":"50","author":"Mathis","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.106.024653_REF24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-3156.2001.00712.x","article-title":"Melarsoprol refractory T. b. gambiense from Omugo, North-Western Uganda","volume":"6","author":"Matovu","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1124\/mol.106.024653_REF25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-6851(01)00332-2","article-title":"Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy","volume":"117","author":"Matovu","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.106.024653_REF26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","article-title":"Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei","volume":"2","author":"Matovu","year":"2003","journal-title":"Eukaryotic Cell"},{"key":"10.1124\/mol.106.024653_REF27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0166-6851(93)90231-L","article-title":"Rapid isolation of DNA from trypanosomatid protozoa using a simple mini-prep procedure","volume":"59","author":"Medina-Acosta","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.106.024653_REF28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-3156.2001.00714.x","article-title":"Re-emergence of epidemic Sleeping Sickness in Southern Sudan","volume":"6","author":"Moore","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1124\/mol.106.024653_REF29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.20506\/rst.22.3.1448","article-title":"Managing animal trypanosomosis in Africa: issues and options","volume":"22","author":"Omamo","year":"2003","journal-title":"Rev Sci Tech"},{"key":"10.1124\/mol.106.024653_REF30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"Pepin","year":"1994","journal-title":"Adv Parasitol"},{"key":"10.1124\/mol.106.024653_REF31","doi-asserted-by":"crossref","first-page":"pp 139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"Raz","year":"1997","journal-title":"Acta Tropica"},{"key":"10.1124\/mol.106.024653_REF32","unstructured":"Sambrook J, Fritsch EF, and Maniatis T (1989) Molecular cloning: A Laboratory Manual, Cold Spring Harbour Laboratory Press, Cold Spring Harbor."},{"key":"10.1124\/mol.106.024653_REF33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/expr.1997.4167","article-title":"Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites","volume":"86","author":"Scott","year":"1997","journal-title":"Exp Parasitol"},{"key":"10.1124\/mol.106.024653_REF34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(05)66793-1","article-title":"Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test","volume":"366","author":"Stewart","year":"2005","journal-title":"Lancet"},{"key":"10.1124\/mol.106.024653_REF35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1471-4922(03)00055-2","article-title":"Waking up to Sleeping Sickness","volume":"19","author":"Stich","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1124\/mol.106.024653_REF36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.actatropica.2004.03.010","article-title":"Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue","volume":"91","author":"Sturk","year":"2004","journal-title":"Acta Tropica"},{"key":"10.1124\/mol.106.024653_REF37","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1023\/A:1020957430400","article-title":"Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl) furan across Caco-2 cell monolayers via its methylamidoxime prodrug","volume":"19","author":"Zhou","year":"2002","journal-title":"Pharm Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24042111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24042111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.024653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:34:48Z","timestamp":1739964888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24042111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0026895X24042111"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.024653","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.024653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}